Bionik Laboratories Corp Receivables Turnover Ratio (BNKL), from the fourth quarter 2023 to the fourth quarter 2022 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Bionik Laboratories Corp   (BNKL)
 

Bionik Laboratories Accounts Receivables Turnover Ratio from the fourth quarter 2023 to the fourth quarter 2022

Quarterly Results, Trends, Rankings, Statistics


Bionik Laboratories Corp 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2023 to a ratio of 4.84, above the company average. This is a clear sign of healthy business climate in the Medical Equipment & Supplies industry and improving liquidity at their respective customers, during the fourth quarter 2023. Average receivable collection period, for the Bionik Laboratories in Mar 31 2023 quarter, has decreased to 75 days, compared to 80 days, in the Dec 31 2022 quarter.

If we take a look into Healthcare sector 445 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2023 from 2926 to 2970.

What is Receivable Turnover Ratio?
What is Bionik Laboratories Corp Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BNKL Receivables Turnover Ratio (Mar 31 2023)
IV. Quarter		 (Dec 31 2022)
III. Quarter		 (Sep 30 2022)
II. Quarter		 (Jun 30 2022)
I. Quarter		 (Mar 31 2022)
IV. Quarter
Y / Y Receivable Change 64.85 % 159.91 % 713.57 % -73.33 % -39.18 %
Y / Y Revenue Change 158.15 % 213.72 % 113.34 % -63.83 % -58.05 %
Receivable Turnover Ratio (TTM) 4.84 4.57 4.01 5.7 5.54
BNKL's Total Ranking # 2970 # 2926 # 2051 # 2234 # 2716
Accounts Receivable average collection period days 75 80 91 64 66
Seq. Receivable Change 34.3 % -41.98 % 388.77 % -56.72 % 111.74 %
Seq. Revenue Change -12.86 % 18.27 % 100.23 % 25.1 % 5.9 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 158
Healthcare Sector # 446
Overall Market # 2970

Receivable Turnover Ratio Statistics
High Average Low
5.86 3.62 2.01
(Jun 30 2022)   (Jun 30 2017)





BNKL Company Profile • Back to BNKL Efficiency Comparisons • Compare BNKL Receivables Turnover Ratio to its Competitors

Financial Statements
Bionik Laboratories 's Accounts Receivable $ 0 Millions Visit BNKL's Balance sheet
Bionik Laboratories 's Sales TTM $ 2 Millions Visit BNKL's Income Statement
Sources of BNKL's Revenues Visit BNKL's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
BNKL's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
BNKL's Growth Rates BNKL's Roa BNKL's Inventory Turnover Ratio BNKL's Dividend Comparisons
BNKL's Profitability Ratios BNKL's Roi BNKL's Asset Turnover Ratio BNKL's Dividend Growth
BNKL's Valuation Ratios BNKL's Roe BNKL's Financial Strength Ratios BNKL's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2023, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Mar 31 2023 Receivable at quarter ending Mar 31 2023
Sigilon Therapeutics Inc   10.88 $ 14.637  Millions$ 1.345  Millions
Semler Scientific inc   10.85 $ 60.876  Millions$ 5.611  Millions
Option Care Health Inc   10.79 $ 4,044.799  Millions$ 374.928  Millions
Intercept Pharmaceuticals inc   10.78 $ 294.522  Millions$ 27.323  Millions
National Healthcare Corp  10.70 $ 1,076.318  Millions$ 100.635  Millions
Mirati Therapeutics Inc   10.66 $ 18.894  Millions$ 1.773  Millions
Hcw Biologics Inc   10.62 $ 3.646  Millions$ 0.343  Millions
Nrc Health  10.47 $ 149.600  Millions$ 14.293  Millions
United Therapeutics Corporation  10.43 $ 1,981.300  Millions$ 190.000  Millions
Utah Medical Products Inc  10.33 $ 52.478  Millions$ 5.082  Millions
Sunlink Health Systems Inc   10.32 $ 46.918  Millions$ 4.545  Millions
Novavax inc   10.27 $ 1,358.852  Millions$ 132.268  Millions
Atrion Corporation  10.17 $ 176.361  Millions$ 17.339  Millions
Ultragenyx Pharmaceutical Inc   10.12 $ 383.890  Millions$ 37.952  Millions
Protalix Biotherapeutics inc   9.94 $ 41.141  Millions$ 4.141  Millions
Poseida Therapeutics Inc   9.92 $ 139.400  Millions$ 14.056  Millions
American Bio Medica Corporation  9.91 $ 0.726  Millions$ 0.073  Millions
Milestone Scientific Inc   9.88 $ 8.703  Millions$ 0.881  Millions
Sunshine Biopharma Inc   9.85 $ 9.117  Millions$ 0.926  Millions
Precipio inc   9.84 $ 9.782  Millions$ 0.994  Millions
Surmodics Inc   9.80 $ 102.973  Millions$ 10.506  Millions
Strata Skin Sciences Inc  9.75 $ 36.687  Millions$ 3.764  Millions
Neuroone Medical Technologies Corp  9.72 $ 0.682  Millions$ 0.070  Millions
Viemed Healthcare Inc   9.59 $ 146.133  Millions$ 15.242  Millions
Titan Pharmaceuticals Inc   9.55 $ 0.463  Millions$ 0.049  Millions
Sanara Medtech Inc   9.51 $ 53.554  Millions$ 5.633  Millions
Myomo Inc   9.46 $ 15.134  Millions$ 1.599  Millions
Femasys Inc   9.46 $ 1.179  Millions$ 0.125  Millions
China Health Industries Holdings Inc   9.31 $ 0.087  Millions$ 0.009  Millions
The Pennant Group Inc   9.30 $ 485.795  Millions$ 52.210  Millions

Date modified: 2026-09-08T15:10:58+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.